fundvisualizer.com

GMO International Equity IGMOUX

Performance (before sales charge)

As of 08/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 05/31/2024
Stock
0.24%
Non-U.S. Stock
97.05%
Bond
5.38%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.02%
Other
-3.68%

Due to rounding, percentages may not equal 100%.

Sectors

As of 05/31/2024

Basic materials

3.28%

Consumer cyclical

14.56%

Financial services

20.05%

Real estate

0.00%

Consumer defensive

5.36%

Health care

9.22%

Utilities

0.18%

Communication services

3.36%

Energy

6.61%

Industrials

23.62%

Technology

10.32%

Top 10 holdings

As of 05/31/2024

Other Liability
7.73%
GMO US Treasury
6.61%
Roche Holding AG
3.03%
TotalEnergies SE
2.72%
3i Group Ord
2.67%
Banco Bilbao Vizcaya Argentaria SA
2.64%
Compagnie de Saint-Gobain SA
2.46%
Banco de Sabadell SA
2.39%
ITOCHU Corp
2.31%
Siemens AG
2.23%
Fund assets

$1.05 Billion

Share class

Inst

Morningstar category

Foreign Large Value

Expense ratio

0.85%

Investment objective

Foreign Stock

Documents